Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-340-2 | CAS number: 119-64-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
Animal experiments in rats investigating toxicokinetics upon single or repeated oral dosing indicated rapid absorption, and elimination mainly via urine. Tetrahydronaphthalin is metabolized by hydroxylation at the non-aromatic portion of the molecule. The metabolites are excreted mainly (generally > 90 %) as glucuronides (cited from SIAR to SIAM 19, 2004)
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Cited from SIAR for SIAM 19 (19-22 October 2004):
Studies in Animals
In vitro Studies
Using a homogenate of male Holtzman rat livers, Chen and Lin (1968) found out that both 1,2,3,4-
tetrahydronaphthalene and its 1-hydroperoxide were converted to tetrahydronaphthalene-1-ol by rat
liver enzymes. Both conversions required NADHP. The authors concluded that hydroxylation of
1,2,3,4-tetrahydronaphthalene probably occurs via the hydroperoxide.
In vivo Studies
The toxicokinetic behavior of 1,2,3,4-tetrahydronaphthalene in rats was studied by Hüls AG
(1995 c) using a modified version of the test method described in Directive 84/449/EEC, and part of
the results was reported by Meineke et al. (1998). Six groups each comprising five Wistar rats per
sex were assigned to the following dose levels: vehicle control (2 groups); 15; 50;
150 mg/kg bw/day; 150 mg/kg bw/day reversal group. 2 ml/kg bw of the vehicle corn oil including
the appropriate doses of 1,2,3,4-tetrahydronaphthalene were applied by gavage for 28 consecutive
days. Blood was sampled from all animals once (terminal) for serum chemical and hematological
investigations plus twice for the toxicokinetics during study (high dose group days 1 and 16;
medium and low dose groups days 3 and 18 of treatment); detailed sampling times (approximately)
were:
- 0.5; 1.5; 3.0; 6.0; 23.0 hours after treatment on days 1 and 16 from one animal per sex and
group each;
- on days 2 and 17 from control groups;
- 0.5; 1.5; 6.0 hours after treatment on days 3 and 18 from 2; 2; 1 animals per sex and group;
- additional sampling from two animals each of the high dose groups at five different times
during the 14 day reversal period (first sampling from non-reversal animals before
sacrifice); 200 - 500μl/sample.
The blood concentration maximum for 1,2,3,4-tetrahydronaphthalene was reached approximately
30 minutes after administration of the highest dose. The AUC (area under curve) of the high dose
groups was more than proportional higher than that of the lower dose groups indicating that
elimination may be saturated at this dose level. An accumulation of test substance after repeated
oral administration of up to 150 mg/kg bw/day was, however, not observed. After 23 hours, only
traces of test substance were detectable in the blood. In the low and mid dose group, elimination
was almost finished after 6 hours. The elimination half life was determined in the range of 30 to
100 minutes. The first order half-life of elimination was approximately 1.5 hours with a onecompartment model and 4.7 hours (for males) with a two-compartment model. The authors
concluded that resorption is rapid, but is probably decreased upon repeated dosing.
IN an NTP study (NTO 2005) toxicokinetic studies were conducted in F344/N rats and B6C3F1 mice to estimate toxicokinetic parameters for the elimination of tetralin from blood. Male and female rats and mice received either a single intravenous dose of 2 or 20 mg tetralin/kg body weight or a single 6‑hour inhalation exposure of 15, 60, or 120 ppm. Post‑dose blood samples were analyzed for tetralin up to 24 hours after dosing and used to estimate the toxicokinetic parameters.
When comparing the elimination kinetics of tetralin in mice to rats receiving equivalent doses by two exposure routes (inhalation and intravenous), mice eliminated tetralin more rapidly than rats. Elimination half-lives were shorter, and AUC values were lower in mice compared to rats at similar doses and exposure concentrations.
The metabolism of 1,2,3,4-tetrahydronaphthalene in Doe albino rabbits after single doses (210 -
approximately 1,000 mg/kg bw) by stomach tube was studied by Elliott and Hanam (1968) using
purified unlabeled as well as radioactive test substance. Of the radioactivity, 87 – 90 % was
excreted in the urine within two days and 0.5 - 3.7 % on the third day. The feces contained 0.6 -
1.8 %. No radioactivity was found in the breath and negligible amounts were retained in the tissue.
The main metabolites in the urine were:
glucuronide of 1,2,3,4-tetrahydro-1-naphthol [1]: 52.4 %
glucuronide of 1,2,3,4-tetrahydro-2-naphthol [2]: 25.3 %
1,2,3,4-tetrahydro-1-oxo-4-naphthol [3] (conjugated): 6.1 %
trans-1,2,3,4-tetrahydronaphthalene-1,2-diol [4] (conjugated): 0.6 %
cis-1,2,3,4-tetrahydronaphthalene-1,2-diol [5] (conjugated): 0.4 %
Previously reported as metabolites, but now identified to be artefacts, were: 1,2,3,4-tetrahydro-2-
oxonaphthalene, 1-naphthol, 1,2-dihydronaphthalene, and naphthalene. The substances 1,2,3,4-
tetrahydronaphthalene (= test substance itself), 1,2,3,4-tetrahydro-1-oxonaphthalene, 2-naphthol,
5,6,7,8-tetrahydro-1-naphthol, and 5,6,7,8-tetrahydro-2-naphthol also could not be found.
Upon treatment of male and female Fischer 344 rats with 0.5 ml 1,2,3,4-tetrahydronaphthalene/kg
bw = 485 mg/kg bw intragastrically on alternate days over a 14 day period, the following
metabolites were found (Servé, 1989; Servé et al., 1989):
1,2,3,4-tetrahydro-1-naphthol [1]: 29 %
1,2,3,4-tetrahydro-2-naphthol [2]: 7 %
1,2,3,4-tetrahydro-1-oxo-2-naphthol [6]: 33 %
1,2,3,4-tetrahydro-1-oxo-4-naphthol [3]: 25 %
1,2,3,4-tetrahydronaphthalene-1,4-diol [7]: 1 %
1,2,3,4-tetrahydronaphthalene-1,2-diol [4] and [5]: traces
The findings of Röckemann (1922) can, due to lacking documentation, only indicate that 1,2,3,4-
tetrahydronaphthalene is metabolized in different ways by rabbits on one hand and by dogs and
humans on the other hand. The main metabolite in rabbits is 1,2,3,4-tetrahydro-1-naphthol [1],
which is excreted as glucuronate. The main metabolite in dogs is 1,2,3,4-tetrahydro-2-naphthol [2],
also excreted as glucuronate. Both main metabolites ([1] more rapidly than [2]) are further
converted into dihydronaphthalene and subsequently into naphthalene. Considering the conflicting
statements of Elliott and Hanam (1968) cited above, who identified 1,2-dihydronaphthalene and
naphthalene as artefacts, one may conclude that there are certainly quantitative and maybe also
qualitative differences between different mammals in their metabolism of 1,2,3,4-tetrahydronaphthalene.
Considering the purity of the test substances and the analytical tools available in the
two studies, the data of Elliott and Hanam (1968) have a much higher reliability than those of
Röckemann (1922). However, the studies of Servé (1989) and co-workers confirm that there are at
least two metabolic pathways in competition with each other.
Studies in Humans
In vitro Studies
There were no studies available
In vivo Studies
Pohl and Rawicz (1919) exposed volunteers through the food to doses of 5 or 7 g 1,2,3,4-tetrahydronaphthalene
and performed various analyses with the urine collected thereafter. Dark green
colored urine was observed, in which an unidentified pigment, naphthalene, and 1,2-dihydronaphthalene
were found.
A woman was admitted to a hospital 48 hours after she had drunk about 250 ml (1/2 - 3/4 pint) of
Cuprex (1,2,3,4-tetrahydronaphthalene 31.5 %, copper oleate 0.03 %, paraffin oil 52.7 %, acetone
15.7 %) in an episode of self-poisoning. A total of 1900 ml of green-grey urine was collected
during the 24 hour period after admission and analyzed for metabolites, which were identified by
comparison of GC retention times and mass spectra with reference compounds. The following
substances were found in the urine beside unchanged 1,2,3,4-tetrahydronaphthalene:
A = 1,2,3,4-tetrahydro-1-naphthol [1]
B = not identified
C = glucuronide of A
D = glucuronide of 1,2,3,4-tetrahydro-2-naphthol [2]
The predominant metabolite was A. The concentration ratios A:B and C:D were approximately
84:16 and 1:2, respectively (Drayer and Reidenberg, 1973).
As mentioned earlier in this chapter, findings of Röckemann (1922) and others give evidence,
however unreliable, that metabolism of 1,2,3,4-tetrahydronaphthalene in humans may be somewhat
different from that in rabbits and rodents in quantitative, but possibly also in qualitative terms.
Conclusion
1,2,3,4-Tetrahydronaphthalene is rapidly absorbed when ingested or inhaled. The chemical is metabolized
by hydroxylation at the non-aromatic portion of the molecule. The metabolites are excreted
mainly (generally > 90 %) as glucuronides with the urine, but elimination with the feces was also
observed. Dark green colored urine, which is observed as a typical symptom in humans, indicates
metabolization to a pigment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.